Reversible pulmonary hypertension in post -renaltransp lantation patient with longst anding arteriovenous fistula-Reference-Cited by-同舟云学术

Reversible pulmonary hypertension in post -renaltransp lantation patient with longst anding arteriovenous fistula

Published:2017-04-14 Issue:1 Volume:19 Page:57-62
ISSN:2412-6160
Container-title:Russian Journal of Transplantology and Artificial Organs
language:
Short-container-title:RJTAO

Author:

Zeltyn-Abramov E. M.¹,Iskhakov R. T.¹,Artyukhina L. Yu.²,Ivanova E. S.²,Manchenko O. V.²,Belavina N. I.²,Tomilina N. A.³

Affiliation:

1. N.I. Pirogov Russian National Research Medical University Moscow City Hospital № 52

2. Moscow City Hospital № 52

3. V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs of the Ministry of Healthcare of the Russian Federation A.I. Evdokimov Moscow State University of Medicine and Dentistry Moscow City Hospital № 52

Abstract

Case report of reversible high pulmonary hypertension (PH) in patient with successful kidney transplantation (KT) is presented. The distinction of the case was the functioning arteriovenous fistula (AVF) with excessive blood flow during 15 years in the absence of indications for hemodialysis. Consequently, PH was complicated by serious congestive heart failure (CHF) with high cardiac output. Surgical closure of AVF resulted in complete regression of clinical, instrumental and laboratory signs and symptoms of PH and CHF within 2 weeks. The pathogenic role of excessive AVF blood flow in PH and CHF formation is a point of discussion. Surgical closure of AVF with excessive blood flow is recommended in cases of presence of symptomatic PH and CHF in patients after successful KT.

Publisher

V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs

Subject

Transplantation,Immunology and Allergy

Reference23 articles.

1. Agarwal R. Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients. Nephrol. Dial. Transplant. 2012; 27: 3908–3914.

2. Ramasubbu K, Deswal A, Herdejurgen C, Aquilar D, Frost AE. A prospective echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States: prevalence and clinical significance. 2010; 3: 279–286.

3. Yigla M, Fruchter O, Aharonson D, Yanay N, Reisner SA et al. Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int. 2009; 75: 969–975.

4. Navaneethan SD, Roy J, Tao K, Brecklin CS, Chen J, Deo R et al. Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD. J. Am. Soc. Nephrol. 2016 Mar; 27 (3): 877–886.

5. Alhamad NE, Al-Ghonaim M, Alfaleh HF, Cal J.P, Said N. Pulmonary hypertention in end-stage renal desease and post renal transplantation patients. J. Thorac. Dis. 2014; 6 (6): 606–616.